<scp>MCM</scp>7 expression predicts post‐operative prognosis for hepatocellular carcinoma

Abstract

The current findings suggested that MCM7 expression may be a useful predictor of prognosis in patients with HCC after resection. Adjuvant therapy with sorafenib might be a valuable therapeutic strategy for MCM7-positive HCC patients.